Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
Xue‐Ning Shen(Fudan University), Mei Cui(Huashan Hospital), Kevin H.M. Kuo(University Health Network), Qiang Dong(Henan Normal University), Jin‐Tai Yu(Fudan University), Shi‐Dong Chen(Fudan University), Lan Tan(Qingdao University), Hong‐Qi Li(Fudan University), Yuxiang Yang(Fudan University)
Cited by 13
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Tauopathies: new perspectives and challenges
|Molecular Neurodegeneration|2022|295
Plasma proteomic profiles predict future dementia in healthy adults
|Nature Aging|2024|258
Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
|Alzheimer s & Dementia|2024|209